Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-068907
Filing Date
2024-08-14
Accepted
2024-08-14 15:18:50
Documents
91
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0210568-10q_abvcbio.htm   iXBRL 10-Q 1200130
2 CERTIFICATION ea021056801ex31-1_abvcbio.htm EX-31.1 11159
3 CERTIFICATION ea021056801ex31-2_abvcbio.htm EX-31.2 10955
4 CERTIFICATION ea021056801ex32-1_abvcbio.htm EX-32.1 4694
5 CERTIFICATION ea021056801ex32-2_abvcbio.htm EX-32.2 4748
  Complete submission text file 0001213900-24-068907.txt   7815565

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE abvc-20240630.xsd EX-101.SCH 82573
7 XBRL CALCULATION FILE abvc-20240630_cal.xml EX-101.CAL 49425
8 XBRL DEFINITION FILE abvc-20240630_def.xml EX-101.DEF 395474
9 XBRL LABEL FILE abvc-20240630_lab.xml EX-101.LAB 698715
10 XBRL PRESENTATION FILE abvc-20240630_pre.xml EX-101.PRE 399113
94 EXTRACTED XBRL INSTANCE DOCUMENT ea0210568-10q_abvcbio_htm.xml XML 876498
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40700 | Film No.: 241206866
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)